ACS Medicinal Chemistry Letters
pubs.acs.org › journal › amclctNov 10, 2015 · New Drug Modalities in Medicinal Chemistry, Pharmacology, and Translational Science. ACS Medicinal Chemistry Letters, ACS Pharmacology & Translational Science, and Journal of Medicinal Chemistry welcome submissions to this joint Virtual Special Issue. Submission deadline: July 31, 2022. Read the Editorial to learn more
ACS Division of Medicinal Chemistry
www.acsmedchem.orgDr. John Macor explains why you should join the ACS Division of Medicinal Chemistry. Regular membership is $25 per year (students $10), and it includes Medicinal Chemistry Reviews, an outstanding 700+ page volume providing timely and critical reviews of important topics in medicinal chemistry.
ACS Bio & Med Chem Au
https://pubs.acs.org/journal/abmcb8Welcome to ACS Bio & Med Chem Au. Squire J. Booker, Stuart J. Conway, and Afsaneh Lavasanifar. Publication Date (Web): September 7, 2021. Identification of a BAZ2A Bromodomain Hit Compound by Fragment Joining. Andrea Dalle Vedove, Giulia Cazzanelli, Jessica Corsi, Maria Sedykh, Vito Giuseppe D’Agostino, Amedeo Caflisch*, and Graziano Lolli*
Journal of Medicinal Chemistry | Vol 63, No 22
pubs.acs.org › toc › jmcmarJournal of Medicinal Chemistry 2020, 63, 22, 13444-13465 (Perspective) Publication Date (Web): August 13, 2020. Abstract. Full text. PDF. ABSTRACT. In the tumor microenvironment, unusually high concentrations of extracellular adenosine promote tumor proliferation through various immunosuppressive mechanisms.
ACS Medicinal Chemistry Letters
https://pubs.acs.org/journal/amclct10.11.2015 · ACS Med. Chem. Lett. All Publications/Website. OR SEARCH CITATIONS ... ACS Medicinal Chemistry Letters, ACS Pharmacology & Translational Science, and Journal of Medicinal Chemistry welcome submissions to this joint Virtual Special Issue. Submission deadline: July 31, 2022.
Journal of Medicinal Chemistry | Vol 64, No 24
pubs.acs.org › toc › jmcmarJournal of Medicinal Chemistry 2021, 64, 21, 15787-15798 (Article) Publication Date (Web): October 27, 2021. Abstract. Full text. PDF. ABSTRACT. Inhibition of TGFβ signaling in concert with a checkpoint blockade has been shown to provide improved and durable antitumor immune response in mouse models.